* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology ROE % Adjusted to Book Value Chart
Alibaba Health Information Technology ROE % Adjusted to Book Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 2.04% mean?
Alibaba Health Information Technology (ALBHF) has a ROE % Adjusted to Book Value of 2.04% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alibaba Health Information Technology and its competitors.
Is Alibaba Health Information Technology's ROE % Adjusted to Book Value too high?
Alibaba Health Information Technology's current ROE % Adjusted to Book Value is 2.04%. Overall, Alibaba Health Information Technology has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's ROE % Adjusted to Book Value compare to competitors?
Alibaba Health Information Technology's ROE % Adjusted to Book Value of 2.04% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Alibaba Health Information Technology and its competitors. Alibaba Health Information Technology's current ROE % Adjusted to Book Value is 2.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBHF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.70, compared to a current price of $0.42 — trading 40% below its estimated fair value. The current ROE % Adjusted to Book Value is 2.04%. Alibaba Health Information Technology's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBHF), the current ROE % Adjusted to Book Value is 2.04% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBHF) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $0.42 is trading 40% below its estimated GF Value™ of $0.70.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBHF:
ROE % Adjusted to Book Value: 2.04%
GF Value™: $0.70 vs. price of $0.42 (40% below fair value)
No single metric tells the full story. See the ALBHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
55GF Score
Get the complete analysis for ALBHF
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBHF has been successfully added to your 
